107 related articles for article (PubMed ID: 10468242)
1. Maintenance of homeostasis in coagulation during cardiopulmonary bypass.
Spiess BD
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):2-5; discussion 36-7. PubMed ID: 10468242
[TBL] [Abstract][Full Text] [Related]
2. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
3. Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass.
van den Goor JM; Nieuwland R; Rutten PM; Tijssen JG; Hau C; Sturk A; Eijsman L; de Mol BA
Eur J Cardiothorac Surg; 2007 Jun; 31(6):1029-36. PubMed ID: 17350849
[TBL] [Abstract][Full Text] [Related]
4. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
[TBL] [Abstract][Full Text] [Related]
5. Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery.
Knudsen L; Hasenkam JM; Kure HH; Hughes P; Bellaiche L; Ahlburg P; Djurhuus C
Thromb Res; 1996 Oct; 84(1):45-54. PubMed ID: 8885146
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass.
Philippou H; Adami A; Davidson SJ; Pepper JR; Burman JF; Lane DA
Thromb Haemost; 2000 Jul; 84(1):124-8. PubMed ID: 10928482
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Despotis GJ; Joist JH
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
[TBL] [Abstract][Full Text] [Related]
8. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass.
Chung JH; Gikakis N; Rao AK; Drake TA; Colman RW; Edmunds LH
Circulation; 1996 Jun; 93(11):2014-8. PubMed ID: 8640976
[TBL] [Abstract][Full Text] [Related]
9. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.
Guzzetta NA; Bajaj T; Fazlollah T; Szlam F; Wilson E; Kaiser A; Tosone SR; Miller BE
Anesth Analg; 2008 Feb; 106(2):419-25, table of contents. PubMed ID: 18227295
[TBL] [Abstract][Full Text] [Related]
10. Thrombin during cardiopulmonary bypass.
Edmunds LH; Colman RW
Ann Thorac Surg; 2006 Dec; 82(6):2315-22. PubMed ID: 17126170
[TBL] [Abstract][Full Text] [Related]
11. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.
Eisses MJ; Chandler WL
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):53-9. PubMed ID: 18249331
[TBL] [Abstract][Full Text] [Related]
12. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
13. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
Hattori T; Khan MM; Colman RW; Edmunds LH
J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor activity is associated with raised lactate levels after cardiac surgery with cardiopulmonary bypass.
Dixon B; Santamaria JD; Campbell DJ
Crit Care Med; 2003 Apr; 31(4):1053-9. PubMed ID: 12682472
[TBL] [Abstract][Full Text] [Related]
15. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system.
Wippermann J; Albes JM; Hartrumpf M; Kaluza M; Vollandt R; Bruhin R; Wahlers T
Eur J Cardiothorac Surg; 2005 Jul; 28(1):127-32. PubMed ID: 15939621
[TBL] [Abstract][Full Text] [Related]
16. Platelet dysfunction after normothermic cardiopulmonary bypass in children: effect of high-dose aprotinin.
Flaujac C; Pouard P; Boutouyrie P; Emmerich J; Bachelot-Loza C; Lasne D
Thromb Haemost; 2007 Aug; 98(2):385-91. PubMed ID: 17721621
[TBL] [Abstract][Full Text] [Related]
17. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
18. [Cardiopulmonary bypass and blood coagulation].
Kitaguchi K; Furuie H
Masui; 2001 Dec; 50 Suppl():S115-20. PubMed ID: 11871083
[No Abstract] [Full Text] [Related]
19. What does it take to make the perfect clot?
Monroe DM; Hoffman M
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):41-8. PubMed ID: 16254201
[TBL] [Abstract][Full Text] [Related]
20. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
Kalweit G; Bach J; Huwer H; Winning J; Hellstern P
Thromb Res; 2005; 116(1):33-9. PubMed ID: 15850606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]